BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21958960)

  • 21. Detection and clinical relevance of donor specific HLA antibodies: a matter of debate.
    Roelen DL; Doxiadis II; Claas FH
    Transpl Int; 2012 Jun; 25(6):604-10. PubMed ID: 22587521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The increasing clinical importance of alloantibodies in kidney transplantation.
    Pankewycz O; Soliman K; Laftavi MR
    Immunol Invest; 2014; 43(8):775-89. PubMed ID: 25296233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac antibody-mediated rejection.
    Chin C
    Pediatr Transplant; 2012 Aug; 16(5):404-12. PubMed ID: 22500558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which human leukocyte antigen antibodies are really clinically relevant?
    Opelz G; Claas FH
    Hum Immunol; 2009 Aug; 70(8):561-2. PubMed ID: 19580832
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation.
    Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G
    J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies.
    Glotz D; Antoine C; Julia P; Pegaz-Fiornet B; Duboust A; Boudjeltia S; Fraoui R; Combes M; Bariety J
    Transpl Int; 2004 Jan; 17(1):1-8. PubMed ID: 14685653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization protocols and their outcome.
    Marfo K; Lu A; Ling M; Akalin E
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):922-36. PubMed ID: 21441131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
    Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
    Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M; Bosio E; Ancona E; Cozzi E
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The (re)emergence of B cells in organ transplantation.
    Stegall MD; Raghavaiah S; Gloor JM
    Curr Opin Organ Transplant; 2010 Aug; 15(4):451-5. PubMed ID: 20613525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
    Sumitran-Holgersson S
    Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preformed cytotoxic antibodies in potential allograft recipients: recent data.
    Cecka JM; Zhang Q; Reed EF
    Hum Immunol; 2005 Apr; 66(4):343-9. PubMed ID: 15866696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bortezomib for acute humoral rejection in two repeat transplant recipients.
    Hardinger KL; Alford K; Murillo D
    Clin Transpl; 2009; ():479-83. PubMed ID: 20524319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
    Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
    Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
    Delville M; Charreau B; Rabant M; Legendre C; Anglicheau D
    Hum Immunol; 2016 Nov; 77(11):1055-1062. PubMed ID: 27237040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Mechanisms of Antibody-Mediated Rejection and Accommodation in Organ Transplantation.
    Kenta I; Takaaki K
    Nephron; 2020; 144 Suppl 1():2-6. PubMed ID: 33238285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of organ transplant rejection by HLA-specific and non-HLA antibodies--brief literature review.
    Slavcev A
    Int J Immunogenet; 2013 Apr; 40(2):83-7. PubMed ID: 22708882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in anti-HLA antibody titers more than 1 year after desensitization therapy with rituximab in living-donor kidney transplantation.
    Takagi T; Ishida H; Shirakawa H; Shimizu T; Tanabe K
    Transpl Immunol; 2010 Aug; 23(4):220-3. PubMed ID: 20598888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.